Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2019, Article ID 4019619, 16 pages
https://doi.org/10.1155/2019/4019619
Research Article

Melatonin Increases Bone Mass around the Prostheses of OVX Rats by Ameliorating Mitochondrial Oxidative Stress via the SIRT3/SOD2 Signaling Pathway

Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou 215006, China

Correspondence should be addressed to Huilin Yang; moc.anis@enipswohcooS, Yaozeng Xu; moc.361@gnezoayux, and Dechun Geng; moc.361@cdgnegzs

Received 14 November 2018; Accepted 5 February 2019; Published 11 April 2019

Academic Editor: Juan C. Mayo

Copyright © 2019 Wei Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Ethgen, O. Bruyère, F. Richy, C. Dardennes, and J. Y. Reginster, “Health-related quality of life in total hip and total knee arthroplasty: a qualitative and systematic review of the literature,” The Journal of Bone & Joint Surgery, vol. 86, no. 5, pp. 963–974, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Patil, D. S. Garbuz, N. V. Greidanus, B. A. Masri, and C. P. Duncan, “Quality of life outcomes in revision vs primary total hip arthroplasty: a prospective cohort study,” The Journal of Arthroplasty, vol. 23, no. 4, pp. 550–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Kurtz, K. Ong, E. Lau, F. Mowat, and M. Halpern, “Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030,” The Journal of Bone and Joint Surgery-American Volume, vol. 89, no. 4, pp. 780–785, 2007. View at Publisher · View at Google Scholar
  4. M. C. S. Inacio, C. F. Ake, E. W. Paxton et al., “Sex and risk of hip implant failure: assessing total hip arthroplasty outcomes in the United States,” JAMA Internal Medicine, vol. 173, no. 6, pp. 435–441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. “NJR 12th Annual Report,” 2015, http://www.njrreports.org.uk/.
  6. O. Furnes, S. A. Lie, B. Espehaug, S. E. Vollset, L. B. Engesaeter, and L. I. Havelin, “Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-99,” The Journal of Bone and Joint Surgery, vol. 83, no. 4, pp. 579–586, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. H. T. Aro, J. J. Alm, N. Moritz, T. J. Mäkinen, and P. Lankinen, “Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women: a 2-year RSA study of 39 patients,” Acta Orthopaedica, vol. 83, no. 2, pp. 107–114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Lacko, D. Schreierová, R. Čellár, and G. Vaško, “Bone remodelling in the proximal femur after uncemented total hip arthroplasty in patients with osteoporosis,” Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca, vol. 82, no. 6, pp. 430–436, 2015. View at Google Scholar
  9. J. Wang, G. Wang, L. Gong et al., “Isopsoralen regulates PPAR‑γ/WNT to inhibit oxidative stress in osteoporosis,” Molecular Medicine Reports, vol. 17, no. 1, pp. 1125–1131, 2018. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Wauquier, L. Leotoing, V. Coxam, J. Guicheux, and Y. Wittrant, “Oxidative stress in bone remodelling and disease,” Trends in Molecular Medicine, vol. 15, no. 10, pp. 468–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. L. C. Manchester, A. Coto-Montes, J. A. Boga et al., “Melatonin: an ancient molecule that makes oxygen metabolically tolerable,” Journal of Pineal Research, vol. 59, no. 4, pp. 403–419, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Takaesu, Y. Komada, and Y. Inoue, “Melatonin profile and its relation to circadian rhythm sleep disorders in Angelman syndrome patients,” Sleep Medicine, vol. 13, no. 9, pp. 1164–1170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. L. Mauriz, P. S. Collado, C. Veneroso, R. J. Reiter, and J. Gonzalez-Gallego, “A review of the molecular aspects of melatonin’s anti-inflammatory actions: recent insights and new perspectives,” Journal of Pineal Research, vol. 54, no. 1, pp. 1–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Ma, Y. Yang, C. Fan et al., “Melatonin as a potential anticarcinogen for non-small-cell lung cancer,” Oncotarget, vol. 7, no. 29, pp. 46768–46784, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. A. G. Wade, I. Ford, G. Crawford et al., “Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety,” BMC Medicine, vol. 8, no. 1, p. 51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Buscemi, B. Vandermeer, N. Hooton et al., “The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis,” Journal of General Internal Medicine, vol. 20, no. 12, pp. 1151–1158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Calvo-Guirado, G. Gómez-Moreno, J. E. Maté-Sánchez, L. López-Marí, R. Delgado-Ruiz, and G. E. Romanos, “Retracted: new bone formation in bone defects after melatonin and porcine bone grafts: experimental study in rabbits,” Clinical Oral Implants Research, vol. 26, no. 4, pp. 399–406, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Salomó-Coll, J. E. Maté-Sánchez de Val, M. P. Ramírez-Fernández, M. Satorres-Nieto, J. Gargallo-Albiol, and J. L. Calvo-Guirado, “Osseoinductive elements for promoting osseointegration around immediate implants: a pilot study in the foxhound dog,” Clinical Oral Implants Research, vol. 27, no. 12, pp. e167–e175, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. A. K. Amstrup, T. Sikjaer, L. Heickendorff, L. Mosekilde, and L. Rejnmark, “Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial,” Journal of Pineal Research, vol. 59, no. 2, pp. 221–229, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Maria and P. A. Witt-Enderby, “Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures,” Journal of Pineal Research, vol. 56, no. 2, pp. 115–125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C. D. Bondi, R. Khairnar, K. M. Kamal, and P. Witt-Enderby, “An early development budget impact model for the use of melatonin in the treatment and prevention of osteoporosi,” Clinical Pharmacology & Biopharmaceutics, vol. 4, no. 1, p. 132, 2015. View at Publisher · View at Google Scholar
  22. Y. Chen, W. Qing, M. Sun, L. Lv, D. Guo, and Y. Jiang, “Melatonin protects hepatocytes against bile acid-induced mitochondrial oxidative stress via the AMPK-SIRT3-SOD2 pathway,” Free Radical Research, vol. 49, no. 10, pp. 1275–1284, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Zhai, B. Li, W. Duan et al., “Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis,” Journal of Pineal Research, vol. 63, no. 2, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Han, H. Wang, L. Li et al., “Melatonin protects against maternal obesity-associated oxidative stress and meiotic defects in oocytes via the SIRT3-SOD2-dependent pathway,” Journal of Pineal Research, vol. 63, no. 3, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Calvo-Guirado, G. Gómez-Moreno, L. López-Marí et al., “Actions of melatonin mixed with collagenized porcine bone versus porcine bone only on osteointegration of dental implants,” Journal of Pineal Research, vol. 48, no. 3, pp. 194–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. M. Kim, T. J. Guzik, Y. H. Zhang et al., “A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation,” Circulation Research, vol. 97, no. 7, pp. 629–636, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Li, L. Su, X. Li et al., “Remote limb ischemic postconditioning protects mouse brain against cerebral ischemia/reperfusion injury via upregulating expression of Nrf2, HO-1 and NQO-1 in mice,” International Journal of Neuroscience, vol. 126, no. 6, pp. 552–559, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. S. L. Ruggiero, B. Mehrotra, T. J. Rosenberg, and S. L. Engroff, “Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases,” Journal of Oral and Maxillofacial Surgery, vol. 62, no. 5, pp. 527–534, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Y. Park-Wyllie, M. M. Mamdani, D. N. Juurlink et al., “Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women,” JAMA, vol. 305, no. 8, pp. 783–789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J. L. Rutkowski, “Combined use of glucocorticoids and bisphosphonates may increase severity of bisphosphonate-related osteonecrosis of the jaw,” The Journal of Oral Implantology, vol. 37, no. 5, p. 505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. McClung, S. T. Harris, P. D. Miller et al., “Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday,” The American Journal of Medicine, vol. 126, no. 1, pp. 13–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. S. R. Cummings, J. San Martin, M. McClung et al., “Denosumab for prevention of fractures in postmenopausal women with osteoporosis,” New England Journal of Medicine, vol. 361, no. 8, pp. 756–765, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Kyrgidis and K. A. Toulis, “Denosumab-related osteonecrosis of the jaws,” Osteoporosis International, vol. 22, no. 1, pp. 369-370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Grady, B. Ettinger, E. Moscarelli et al., “Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation,” Obstetrics and Gynecology, vol. 104, no. 4, pp. 837–844, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. L. Vahle, M. Sato, G. G. Long et al., “Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety,” Toxicologic Pathology, vol. 30, no. 3, pp. 312–321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Franceschini Mitri, M. Yoshimoto, S. Allegrini Júnior, S. Koo, M. José Carbonari, and B. König Júnior, “Histological findings in titanium implants coated with calcium phosphate ceramics installed in rabbit’s tibias,” Annals of Anatomy - Anatomischer Anzeiger, vol. 187, no. 1, pp. 93–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. C. de Carvalho Lopes and B. König Júnior, “Histological findings of bone remodeling around smooth dental titanium implants inserted in rabbit’s tibias,” Annals of Anatomy - Anatomischer Anzeiger, vol. 184, no. 4, pp. 359–362, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Dahlin, L. Sennerby, U. Lekholm, A. Linde, and S. Nyman, “Generation of new bone around titanium implants using a membrane technique: an experimental study in rabbits,” International Journal of Oral and Maxillofacial Implants, vol. 4, no. 1, pp. 19–25, 1989. View at Google Scholar
  39. I. R. Garrett, B. F. Boyce, R. O. Oreffo, L. Bonewald, J. Poser, and G. R. Mundy, “Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo,” The Journal of Clinical Investigation, vol. 85, no. 3, pp. 632–639, 1990. View at Publisher · View at Google Scholar · View at Scopus
  40. I. F. Tresguerres, C. Clemente, L. Blanco, A. Khraisat, F. Tamimi, and J. A. F. Tresguerres, “Effects of local melatonin application on implant osseointegration,” Clinical Implant Dentistry and Related Research, vol. 14, no. 3, pp. 395–399, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. J. L. Calvo-Guirado, M. P. Ramírez-Fernández, G. Gómez-Moreno et al., “Melatonin stimulates the growth of new bone around implants in the tibia of rabbits,” Journal of Pineal Research, vol. 49, no. 4, pp. 356–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Cutando, G. Gómez-Moreno, C. Arana et al., “Melatonin stimulates osteointegration of dental implants,” Journal of Pineal Research, vol. 45, no. 2, pp. 174–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. O. Nakade, H. Koyama, H. Ariji, A. Yajima, and T. Kaku, “Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro,” Journal of Pineal Research, vol. 27, no. 2, pp. 106–110, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. J. A. Roth, B. G. Kim, W. L. Lin, and M. I. Cho, “Melatonin promotes osteoblast differentiation and bone formation,” The Journal of Biological Chemistry, vol. 274, no. 31, pp. 22041–22047, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. N. M. Radio, J. S. Doctor, and P. A. Witt-Enderby, “Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade,” Journal of Pineal Research, vol. 40, no. 4, pp. 332–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Masi and M. L. Brandi, “Physiopathological basis of bone turnover,” The Quarterly Journal of Nuclear Medicine, vol. 45, no. 1, pp. 2–6, 2001. View at Google Scholar
  47. M. N. Weitzmann and R. Pacifici, “Estrogen deficiency and bone loss: an inflammatory tale,” Journal of Clinical Investigation, vol. 116, no. 5, pp. 1186–1194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. J. M. Halleen, S. Räisänen, J. J. Salo et al., “Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase,” Journal of Biological Chemistry, vol. 274, no. 33, pp. 22907–22910, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. D. X. Tan, L. D. Chen, B. Poeggeler, L. C. Manchester, and R. J. Reiter, “Melatonin : a potent, endogenous hydroxyl radical scavenger,” Endocrine Journal, vol. 1, pp. 57–60, 1993. View at Google Scholar
  50. R. J. Reiter, J. C. Mayo, D. X. Tan, R. M. Sainz, M. Alatorre-Jimenez, and L. Qin, “Melatonin as an antioxidant: under promises but over delivers,” Journal of Pineal Research, vol. 61, no. 3, pp. 253–278, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. A. S. Hebert, K. E. Dittenhafer-Reed, W. Yu et al., “Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome,” Molecular Cell, vol. 49, no. 1, pp. 186–199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Tao, M. C. Coleman, J. D. Pennington et al., “Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress,” Molecular Cell, vol. 40, no. 6, pp. 893–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Chen, J. Zhang, Y. Lin et al., “Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS,” EMBO Reports, vol. 12, no. 6, pp. 534–541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. X. Qiu, K. Brown, M. D. Hirschey, E. Verdin, and D. Chen, “Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation,” Cell Metabolism, vol. 12, no. 6, pp. 662–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Lu, K. Cheng, B. Zhang et al., “Novel mechanisms for superoxide-scavenging activity of human manganese superoxide dismutase determined by the K68 key acetylation site,” Free Radical Biology & Medicine, vol. 85, pp. 114–126, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Fang, H. Yamaza, T. Uchiumi et al., “Dihydroorotate dehydrogenase depletion hampers mitochondrial function and osteogenic differentiation in osteoblasts,” European Journal of Oral Sciences, vol. 124, no. 3, pp. 241–245, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. P. H. Tsai, Y. Chien, J. H. Chuang et al., “Dysregulation of mitochondrial functions and osteogenic differentiation in Cisd2-deficient murine induced pluripotent stem cells,” Stem Cells and Development, vol. 24, no. 21, pp. 2561–2576, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. I. K. Kwon, S. C. Lee, Y. S. Hwang, and J. S. Heo, “Mitochondrial function contributes to oxysterol-induced osteogenic differentiation in mouse embryonic stem cells,” Biochimica et Biophysica Acta, vol. 1853, no. 3, pp. 561–572, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. C. T. Chen, Y. R. V. Shih, T. K. Kuo, O. K. Lee, and Y. H. Wei, “Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells,” Stem Cells, vol. 26, no. 4, pp. 960–968, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Ding, H. Yang, Y. Wang, J. Chen, Z. Ji, and H. Sun, “Sirtuin 3 is required for osteogenic differentiation through maintenance of PGC-1ɑ-SOD2-mediated regulation of mitochondrial function,” International Journal of Biological Sciences, vol. 13, no. 2, pp. 254–264, 2017. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Gao, Z. Zheng, Q. Gu, X. Chen, X. Liu, and X. Xu, “Deacetylation of MnSOD by PARP-regulated SIRT3 protects retinal capillary endothelial cells from hyperglycemia-induced damage,” Biochemical and Biophysical Research Communications, vol. 472, no. 3, pp. 425–431, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Pi, S. Xu, R. J. Reiter et al., “SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin,” Autophagy, vol. 11, no. 7, pp. 1037–1051, 2015. View at Publisher · View at Google Scholar · View at Scopus